This is because studies have reported that BDNF, GDNF, and GFAP are intimately associated with gliomas as well as tumourigenicity, progression, and prognosis, and high levels of BDNF, GDNF, and GFAP can significantly promote glioma viability 4, 5, 33. This evidence concerns the gene GFAP and central nervous system cancer.